Differences in methylphenidate dose response between periadolescent and adult rats in the familiar arena-novel alcove task

Journal of Pharmacology and Experimental Therapeutics

Volumn 337, Issue 1, 2011, Pages 83-91

  Levant, Beth ^a   Zarcone, Troy J ^b,d   Davis, Paul F ^a   Ozias, Marlies K ^a   Fowler, Stephen C ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; METHYLPHENIDATE;

ADOLESCENT; ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; EXPLORATORY BEHAVIOR; FAMILIAL ARENA NOVEL ALCOVE TASK; FRONTAL CORTEX; HABITUATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; TASK PERFORMANCE;

AGE FACTORS; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; METHYLPHENIDATE; PROTEIN BINDING; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; RECOGNITION (PSYCHOLOGY); SEXUAL MATURATION;

EID: 79953001974     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.174425     Document Type: Article

References (41)

1. Askenasy EP, Taber KH, Yang PB, and Dafny N (2007) Methylphenidate (Ritalin): behavioral studies in the rat. Int J Neurosci 117:757-794. (Pubitemid 46650678)
2. Berlyne DE (1969) Arousal, reward and learning. Ann NY Acad Sci 159:1059-1070.
3. Brockel BJ and Fowler SC (1995) Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine. J Pharmacol Exp Ther 275:1090-1098. (Pubitemid 26129909)
4. Carlsson SG (1972) Effects of apomorphine on exploration. Physiol Behav 9:127-129.
5. Cohen J, Cohen P, West SG, and Aiken LS (2003) Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates, Mahwah, NJ.
6. Costall B and Naylor RJ (1975) Actions of dopaminergic agonists on motor function. Adv Neurol 9:285-297.
7. Faraone SV and Glatt SJ (2009) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71:754-763.
8. Fowler SC, Birkestrand BR, Chen R, Moss SJ, Vorontsova E, Wang G, and Zarcone TJ (2001) A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods 107:107-124. (Pubitemid 32487615)
9. Fowler SC, Zarcone TJ, and Levant B (2010) Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer. J Neurosci Methods 189:36-43.
10. Galineau L, Kodas E, Guilloteau D, Vilar MP, and Chalon S (2004) Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study. Neurosci Lett 363:266-271. (Pubitemid 38746526)
11. Gupta BD, Dandiya PC, and Gupta ML (1971) A psycho-pharmacological analysis of behaviour in rats. Jpn J Pharmacol 21:293-298.
12. Han DD and Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6.
13. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed., Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
14. Kimko HC, Cross JT, and Abernethy DR (1999) Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet 37:457-470. (Pubitemid 30032250)
15. Kollins SH, English J, Robinson R, Hallyburton M, and Chrisman AK (2009) Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) 204:73-83.
16. Kuczenski R and Segal DS (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264-7271.
17. Leslie CA, Robertson MW, Cutler AJ, and Bennett JP Jr (1991) Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis. Brain Res Dev Brain Res 62:109-114.
18. Leussis MP and Bolivar VJ (2006) Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 30:1045-1064. (Pubitemid 44308646)
19. Levant B (2003) Dopamine receptor binding and quantitative autoradiographic study. Methods Mol Med 79:297-313.
20. Levant B, Ozias MK, Davis PF, Winter M, Russell KL, Carlson SE, Reed GA, and McCarson KE (2008) Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 33:1279-1292.
21. Levant B, Zarcone TJ, and Fowler SC (2010) Developmental effects of dietary n-3 fatty acids on activity and response to novelty. Physiol Behav 101:176-183.
22. Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, and Blakely RD (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28:7040-7046.
23. Moll GH, Heinrich H, Trott G, Wirth S, and Rothenberger A (2000) Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 284:121-125. (Pubitemid 30193214)
24. Noisin EL and Thomas WE (1988) Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex. Brain Res 469:241-252.
25. Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, and Markowitz JS (2007) Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 81:346-353. (Pubitemid 46364487)
26. Polanczyk G, de Lima MS, Horta BL, Biederman J, and Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948. (Pubitemid 46972911)
27. Rao PA, Molinoff PB, and Joyce JN (1991) Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res 60:161-177.
28. Sagvolden T and Sergeant JA (1998) Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour. Behav Brain Res 94:1-10. (Pubitemid 28352459)
29. Simon V, Czobor P, Bálint S, Mészáros A, and Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194:204-211.
30. Skjoldager P and Fowler SC (1991) Scopolamine attenuates the motor disruptions but not the attentional disturbances induced by haloperidol in a sustained attention task in the rat. Psychopharmacology (Berl) 105:93-100.
31. Sleator EK and Ullmann RK (1981) Can the physician diagnose hyperactivity in the office? Pediatrics 67:13-17.
32. Sofia RD (1969) Effects of chlorpromazine and d-amphetamine in Long Evans rats of different age, body weight and brain weight. Arch Int Pharmacodyn Ther 182:139-146.
33. Spear LP and Brake SC (1983) Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16:83-109.
34. Thai DL, Yurasits LN, Rudolph GR, and Perel JM (1999) Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs. Drug Metab Dispos 27:645-650. (Pubitemid 29252437)
35. Tripp G and Wickens JR (2009) Neurobiology of ADHD. Neuropharmacology 57:579-589.
36. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, and Gabrieli JD (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95:14494-14499. (Pubitemid 28549395)
37. Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, and Breese GR (1983) Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 226:382-386. (Pubitemid 13041511)
38. Wigal SB (2009) Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 23 (Suppl 1):21-31.
39. Wilens TE (2008) Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 28:S46-S53.
40. Wilens TE, Biederman J, and Spencer TJ (2002) Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53:113-131. (Pubitemid 34177874)
41. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966-2979.